QIM
PBYI icon

Quantitative Investment Management’s Puma Biotechnology PBYI Stock Holding History

Quantitative Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-33,372
Closed -$342K – 627
2020
Q4 		$342K Buy
+33,372
New +$338K 0.03% 386
2020
Q3 		– Sell
-42,643
Closed -$444K – 555
2020
Q2 		$444K Buy
+42,643
New +$441K 0.05% 360
2017
Q4 		– Sell
-30,000
Closed -$3.59M – 853
2017
Q3 		$3.59M Sell
30,000
-49,400
-62% -$4.59M 0.04% 401
2017
Q2 		$6.94M Buy
+79,400
New +$4.44M 0.1% 249
2016
Q3 		– Sell
-14,300
Closed -$425K – 827
2016
Q2 		$425K Buy
+14,300
New +$447K 0.02% 573
2015
Q3 		– Sell
-4,300
Closed -$502K – 766
2015
Q2 		$502K Buy
+4,300
New +$779K 0.08% 232

Other funds holding PBYI

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Quantitative Investment Management's PBYI Position: Q1 2021 in Review

Quantitative Investment Management sold out of Puma Biotechnology (PBYI) in Q1 2021, closing a stake of 33,372 shares — an estimated $342K sold.

Quantitative Investment Management first reported a position in PBYI in Q2 2015 and held it in 6 quarters. The position peaked at $6.94M in Q2 2017. 118 funds tracked by Wall St. Rank hold PBYI as of Q1 2021.

  • Quantitative Investment Management reported no remaining Puma Biotechnology position as of Q1 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 33,372 Puma Biotechnology shares in Q1 2021, an estimated $342K.
  • Quantitative Investment Management first reported a position in Puma Biotechnology in Q2 2015 and held it in 6 quarters.
  • Quantitative Investment Management's Puma Biotechnology position peaked at $6.94M in Q2 2017.
  • 118 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2021.

Based on Quantitative Investment Management's 13F filing for Q1 2021, filed 17 May 2021.